Intercept Pharmaceuticals, Inc.

MARSHALL WACE, LLP

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

22,500

Value ($000)

417

Weight

0.0%

2020 Q3 - 2023 Q3 (9 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	417	0.0%	22,500	9/30/2023
2023 Q2	8/14/2023	241	0.0%	21,820	6/30/2023
2023 Q1	5/15/2023	1,522	0.0%	113,321	3/31/2023
2022 Q1	5/16/2022	436	0.0%	26,836	3/31/2022
2021 Q4	2/14/2022	669	0.0%	41,028	12/31/2021
2021 Q3	11/15/2021	1,635	0.0%	110,085	9/30/2021
2021 Q1	5/17/2021	1,772	0.0%	76,723	3/31/2021
2020 Q4	2/16/2021	1,814	0.0%	73,433	12/31/2020
2020 Q3	11/16/2020	1,602	0.0%	38,628	9/30/2020